Skip to content

Main Navigation

Clinical Study

APD334-210 Gladiator UC: A Randomized, Double-Blind, Placebo-Controlled, 52-Week Study to Assess the Efficacy and Safety of Etrasimod in Subjects with Moderately Active Ulcerative Colitis

A 52-Week Study to Assess the Efficacy and Safety of Etrasimod in Subjects with Moderately Active Ulcerative Colitis

I AM INTERESTED

For more information contact:

Julie Will

  julie.will@hsc.utah.edu
  8015879060

IRB#: IRB_00145459 | PI: John Valentine | Department: GASTROENTEROLOGY | Approval Date: 2022-02-23 07:00:00
Specialties: Gastroenterology

Who can participate?

 Gender: All

 Age: Over 18 years old

 Volunteers: Volunteers with special conditions

 Location: In Person


Will I be paid for my time?

Yes

Last Updated: 4/5/21